Lunt Capital Management, Inc. Clene Inc. Transaction History

Lunt Capital Management, Inc.

  • $214 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$0.31 - $0.44 $24,180 - $34,320
78,000 Added 15.21%
590,863 $210 Million
Q2 2023

Aug 11, 2023
BUY
$0.78 - $1.22 $400,033 - $625,692
512,863 New
512,863 $451 Million

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $279M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Lunt Capital Management, Inc. Portfolio

Follow Lunt Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lunt Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lunt Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email